Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros


Bases de datos
Año de publicación
Tipo del documento
Intervalo de año de publicación
1.
Int Arch Allergy Immunol ; 116(1): 60-6, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9623511

RESUMEN

A group of 9 Mexican lepromatous leprosy patients was studied at the beginning of a type II reaction (erythema nodosum leprosum, ENL) and after 1 or 2 months of thalidomide treatment. ENL patients at the onset of the reaction had slightly higher amounts of anti-Mycobacterium leprae IgG1 and IgG2 antibodies, compared to similar lepromatous patients that did not develop ENL. Neither these antibody levels nor IgM and the other IgG subclasses were importantly modified after thalidomide treatment. Serum TNF was significantly higher in the patients that developed ENL compared to those that did not develop the reaction. TNF levels were slightly decreased after 1 month of thalidomide treatment and significantly decreased after 2 months of treatment. Serum IFN-gamma was significantly lower in patients at the onset of ENL and was increased after 1 and 2 months of thalidomide treatment.


Asunto(s)
Anticuerpos Antibacterianos/clasificación , Eritema Nudoso/inducido químicamente , Inmunoglobulina G/sangre , Inmunoglobulina G/clasificación , Interferón gamma/metabolismo , Leprostáticos/uso terapéutico , Lepra Lepromatosa/tratamiento farmacológico , Talidomida/uso terapéutico , Factor de Necrosis Tumoral alfa/metabolismo , Adolescente , Adulto , Anciano , Anticuerpos Antibacterianos/sangre , Interpretación Estadística de Datos , Femenino , Humanos , Inmunoglobulina M/sangre , Inmunoglobulina M/clasificación , Interferón gamma/sangre , Leprostáticos/administración & dosificación , Leprostáticos/efectos adversos , Lepra Dimorfa/sangre , Lepra Dimorfa/tratamiento farmacológico , Lepra Lepromatosa/metabolismo , Lepra Tuberculoide/sangre , Lepra Tuberculoide/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Mycobacterium leprae/inmunología , Talidomida/administración & dosificación , Talidomida/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA